Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEMG
3451
PUT
DELISTED
SEMGROUP CORPORATION
SEMG
| $2.12M | ﹤0.01% |
59,900
-27,400
| -31% | -$871K |
|
3452
RPM International
RPM
$13.6B
| $2.12M | ﹤0.01% |
39,400
+26,200
| +198% | +$1.39M |
|
3453
CALL
Teleflex
TFX
$5.92B
| $2.12M | ﹤0.01% |
12,600
+8,800
| +232% | +$1.58M |
|
3454
ProShares Ultra Yen
YCL
$31.9M
| $2.12M | ﹤0.01% |
28,409
+2,009
| +8% | +$147K |
|
3455
PUT
AZZ Inc
AZZ
$4.16B
| $2.12M | ﹤0.01% |
+32,400
| New | +$2.07M |
|
3456
CALL
Carlyle Group
CG
$17.5B
| $2.11M | ﹤0.01% |
135,800
-194,600
| -59% | -$3.14M |
|
3457
Coca-Cola Consolidated
COKE
$13.2B
| $2.11M | ﹤0.01% |
142,620
+74,980
| +111% | +$1.11M |
|
3458
Royal Gold
RGLD
$22.3B
| $2.11M | ﹤0.01% |
+27,251
| New | +$2.19M |
|
|
CIM
3459
CALL
Chimera Investment
CIM
$963M
| $2.11M | ﹤0.01% |
44,067
-28,133
| -39% | -$1.38M |
|
3460
Cencora
COR
$61.5B
| $2.11M | ﹤0.01% |
26,100
-126,681
| -83% | -$10.9M |
|
|
FIG
3461
DELISTED
Fortress Investment Group Llc
FIG
| $2.11M | ﹤0.01% |
426,577
-122,018
| -22% | -$600K |
|
3462
PUT
CBRE Group
CBRE
$43.7B
| $2.11M | ﹤0.01% |
75,300
+28,300
| +60% | +$808K |
|
|
UN
3463
PUT
DELISTED
Unilever NV New York Registry Shares
UN
| $2.11M | ﹤0.01% |
45,700
+16,100
| +54% | +$742K |
|
|
EV
3464
CALL
DELISTED
Eaton Vance Corp.
EV
| $2.1M | ﹤0.01% |
53,900
+19,400
| +56% | +$742K |
|
|
DPLO
3465
PUT
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.1M | ﹤0.01% |
75,100
+38,200
| +104% | +$1.28M |
|
|
SIR
3466
DELISTED
SELECT INCOME REIT
SIR
| $2.1M | ﹤0.01% |
177,864
+1,162
| +0.7% | +$13.8K |
|
3467
iShares Intermediate Government/Credit Bond ETF
GVI
$3.81B
| $2.1M | ﹤0.01% |
18,627
-52,474
| -74% | -$5.92M |
|
|
RSPP
3468
PUT
DELISTED
RSP Permian, Inc.
RSPP
| $2.1M | ﹤0.01% |
54,200
+22,600
| +72% | +$836K |
|
|
CPN
3469
DELISTED
Calpine Corporation
CPN
| $2.1M | ﹤0.01% |
+166,293
| New | +$2.24M |
|
3470
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$388M
| $2.1M | ﹤0.01% |
43,234
+14,453
| +50% | +$708K |
|
3471
Broadridge
BR
$20.9B
| $2.1M | ﹤0.01% |
30,968
+17,968
| +138% | +$1.23M |
|
|
AVTA
3472
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.1M | ﹤0.01% |
187,400
-11,300
| -6% | -$126K |
|
3473
Bank of Montreal
BMO
$120B
| $2.1M | ﹤0.01% |
32,000
-87,637
| -73% | -$5.7M |
|
3474
State Street Technology Select Sector SPDR ETF
XLK
$121B
| $2.1M | ﹤0.01% |
87,740
-244,836
| -74% | -$5.69M |
|
|
COR
3475
DELISTED
Coresite Realty Corporation
COR
| $2.1M | ﹤0.01% |
+28,314
| New | +$2.3M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.